Amendment ID: S2898-34

Amendment 34

Reimbursement for Opioid Use Disorder Medication

Mr. Keenan moves that the proposed new text be amended in section 1 by striking, in lines 3 to 20, inclusive, paragraph (a) and (b) and inserting in place thereof the following:-

"Section 17T. (a) Coverage offered by the commission to an active or retired employee of  the commonwealth insured under the group insurance commission shall provide coverage for prescribed or dispensed opioid antagonists, including opioid antagonists as defined in section 19B of chapter 94C, and opioid agonists, including partial agonists which shall be deemed medically necessary and shall not require prior authorization; provided, however, that a prescription from a health care practitioner shall not be required for coverage of opioid antagonists and opioid agonists, including partial agonists. An opioid antagonist and an opioid agonist, including partial agonists, shall not be subject to any deductible, coinsurance, copayments or out-of-pocket limits; provided, however, that cost-sharing shall be required if the applicable plan is governed by the Internal Revenue Code and would lose its tax-exempt status as a result of the prohibition on cost-sharing for this service.

(b) The commission shall provide coverage for an opioid antagonist and an opioid agonist, including partial agonists, as a medical benefit when dispensed by the health care facility, including substance use treatment facility, in which the opioid antagonist or opioid agonist, including partial agonists,  was prescribed or ordered and shall provide coverage as a pharmacy benefit for an opioid antagonist and an opioid agonist, including partial agonists, dispensed by a pharmacist, including an opioid antagonist and an opioid agonist, including partial agonists, dispensed pursuant to section 19B of chapter 94C; provided, however, that the rate to be reimbursed under the medical benefit shall not exceed the commission’s average in-network pharmacy benefit rate and the health care facility shall not balance bill the patient. If dispensed directly to the patient, the commission shall ensure cost to the health care facility is covered through reimbursement or other mechanism as determined by the commission in consultation with the Department of Public Health and the Division of Insurance."

in section 7 by striking, in lines 314 to 335, inclusive, paragraph (a) and (b) and inserting in place thereof the following:-

"Section 10R. (a) The division and its contracted health insurers, health plans, health maintenance organizations, behavioral health management firms and third-party administrators under contract to a Medicaid managed care organization, accountable care organization or primary care clinician plan shall provide coverage for prescribed or dispensed opioid antagonists, including opioid antagonists, as defined in section 19B of chapter 94C, and opioid agonists, including partial agonists, which shall be deemed medically necessary and shall not require prior authorization; provided, however, that a prescription from a health care practitioner shall not be required for coverage of opioid antagonists and opioid agonists, including partial agonists. An opioid antagonist and an opioid agonist, including partial agonists, shall not be subject to any deductible, coinsurance, copayments or out-of-pocket limits; provided, however, that cost-sharing shall be required if the applicable plan is governed by the Internal Revenue Code and would lose its tax-exempt status as a result of the prohibition on cost-sharing for this service.

(b) The division and its contracted health insurers, health plans, health maintenance organizations, behavioral health management firms and third-party administrators under contract to a Medicaid managed care organization, accountable care organization or primary care clinician plan shall provide coverage for an opioid antagonist and an opioid agonists, including partial agonists, as a medical benefit when dispensed by the health care facility, including substance use treatment facility,  in which the opioid antagonist or opioid agonists, including partial agonists, was prescribed or ordered and shall provide coverage as a pharmacy benefit for an opioid antagonist and an opioid agonists, including partial agonists, dispensed by a pharmacist, including an opioid antagonist and an opioid agonists, including partial agonists, dispensed pursuant to section 19B of chapter 94C; provided, however, that the rate to be reimbursed under the medical benefit shall not exceed the carrier’s average in-network pharmacy benefit rate and the health care facility shall not balance bill the patient. If dispensed directly to the patient, the division shall ensure cost to the health care facility is covered through reimbursement or other mechanism as determined by the division in consultation with the Department of Public Health and the Division of Insurance."

in section 8 by striking, in lines 347 to 365, inclusive, paragraph (a) and (b) and inserting in place thereof the following:-

"Section 47VV. (a) Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth, which is considered creditable coverage under section 1 of chapter 111M, shall provide coverage for prescribed or dispensed opioid antagonists, including opioid antagonists as defined in section 19B of chapter 94C, and opioid agonists, including partial agonists which shall be deemed medically necessary and shall not require prior authorization; provided, however, that a prescription from a health care practitioner shall not be required for coverage of opioid antagonists and opioid agonists, including partial agonists. An opioid antagonist and an opioid agonist, including partial agonists, shall not be subject to any deductible, coinsurance, copayments or out-of-pocket limits; provided, however, that cost-sharing shall be required if the applicable plan is governed by the Internal Revenue Code and would lose its tax-exempt status as a result of the prohibition on cost-sharing for this service.

(b) The policy, contract, agreement, plan or certificate of insurance shall provide coverage for an opioid antagonist and an opioid agonist, including partial agonists, as a medical benefit when dispensed by the health care facility, including substance use treatment facility, in which the opioid antagonist or opioid agonist, including partial agonists,  was prescribed or ordered and shall provide coverage as a pharmacy benefit for an opioid antagonist and an opioid agonist, including partial agonists, dispensed by a pharmacist, including an opioid antagonist and an opioid agonist, including partial agonists, dispensed pursuant to section 19B of chapter 94C; provided, however, that the rate to be reimbursed under the medical benefit shall not exceed the carrier’s average in-network pharmacy benefit rate and the health care facility shall not balance bill the patient. If dispensed directly to the patient, the division shall ensure cost to the health care facility is covered through reimbursement or other mechanism as determined by the commission in consultation with the Department of Public Health and the Division of Insurance."